GABRIELLE RILEY: Open Payments
NPI 1710690268 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 10 payments from 3 companies in 2025. Trend: 2023 $606 · 2024 $477 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $240 |
| Alkermes, Inc. | 2 | $195 |
| Otsuka America Pharmaceutical, Inc. | 1 | $100 |
Products named: VRAYLAR, ARISTADA, REXULTI, LYBALVI.
Industry payments across MD — which companies pay providers there.
